![]() | Giovannini, M., Bosi, E., Vieri, W., PRESTA, L., Viciani, E., Bernabei, I., Nannini, G., Stares, M. D., Browne, H., Lawley, T. D., SAUTER, T., LETELLIER, E., KARTA, J., Amedei, A., Fani, R., & Fondi, M. (2026). Modelling Fusobacterium lifestyles transitions by integrating transcriptomics and growth data. Current research in microbial sciences, 10, 100573. doi:10.1016/j.crmicr.2026.100573 Peer reviewed |
![]() | KARTA, J.* , MEYERS, M.* , RODRIGUEZ, F., KONCINA, E., GILSON, C., KLEIN, E., GABOLA, M., BENZARTI, M., PEREZ ESCRIVA, P., MOLINA TIJERAS, J. A., CORREIA TAVARES BERNARDINO, C., Ponath, F., Carpentier, A., Pujabet, M. A., SCHMOETTEN, M., TSENKOVA, M., SAOUD, P., GAIGNEAUX, A., TERNES, D., ... LETELLIER, E. (October 2025). Fusobacterium nucleatum interacts with cancer-associated fibroblasts to promote colorectal cancer. EMBO Journal, 44 (19), 5375 - 5393. doi:10.1038/s44318-025-00542-w Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
![]() | KONCINA, E., NURMIK, M., POZDEEV, V., GILSON, C., TSENKOVA, M., BEGAJ, R., Stang, S., GAIGNEAUX, A., Weindorfer, C., RODRIGUEZ, F., SCHMOETTEN, M., KLEIN, E., KARTA, J., Atanasova, V. S., GRZYB, K., ULLMANN, P., HALDER, R., Hengstschläger, M., Graas, J., ... LETELLIER, E. (17 July 2023). IL1R1+ cancer-associated fibroblasts drive tumor development and immunosuppression in colorectal cancer. Nature Communications, 14 (1), 4251. doi:10.1038/s41467-023-39953-w Peer Reviewed verified by ORBi |
KARTA, J. (2022). Deciphering the role of colorectal cancer-associated bacteria in the fibroblast-tumor cell interaction [Doctoral thesis, Unilu - University of Luxembourg]. ORBilu-University of Luxembourg. https://orbilu.uni.lu/handle/10993/51650 |
![]() | TERNES, D., TSENKOVA, M., POZDEEV, V., MEYERS, M., KONCINA, E., ATATRI, S., SCHMITZ, M., KARTA, J., SCHMOETTEN, M., Heinken, A., RODRIGUEZ, F., Delbrouck, C., GAIGNEAUX, A., GINOLHAC, A., Dan Nguyen, T. T., Grandmougin, L., Frachet-Bour, A., Martin-Gallausiaux, C., PIRES PACHECO, M. I., ... LETELLIER, E. (2022). The gut microbial metabolite formate exacerbates colorectal cancer progression. Nature Metabolism. doi:10.1038/s42255-022-00558-0 Peer Reviewed verified by ORBi |
![]() | KARTA, J., BOSSICARD, Y., KOTZAMANIS, K., Dolznig, H., & LETELLIER, E. (2021). Mapping the Metabolic Networks of Tumor Cells and Cancer-Associated Fibroblasts. Cells. doi:10.3390/cells10020304 Peer Reviewed verified by ORBi |
![]() | TERNES, D., KARTA, J., TSENKOVA, M., KONCINA, E., SCHMITZ, M., GRANDMOUGIN, L., GINOLHAC, A., GAIGNEAUX, A., RAMIRO GARCIA, J., WILMES, P., HAAN, S., & LETELLIER, E. (22 February 2020). Understanding the role of Fusobacterium nucleatum metabolism in colon cancer initiation and progression [Poster presentation]. The Microbiome, Viruses, and Cancer, Orlando, United States. |
![]() | TERNES, D., KARTA, J., TSENKOVA, M., WILMES, P., HAAN, S., & LETELLIER, E. (2020). Microbiome in Colorectal Cancer: How to Getfrom Meta-omics to Mechanism? Trends in Microbiology. doi:10.1016/j.tim.2020.01.001 Peer Reviewed verified by ORBi |